ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

J90 NurExone Biologic Inc

0.302
-0.044 (-12.72%)
04:01:51 - Realtime Data
Share Name Share Symbol Market Stock Type
NurExone Biologic Inc J90 Tradegate Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.044 -12.72% 0.302 04:01:51
Open Price Low Price High Price Close Price Previous Close
0.308 0.29 0.356 0.346
more quote information »

Recent News

Date Time Source Heading
5/29/202407:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
5/17/202415:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
4/25/202407:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
4/19/202415:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
4/02/202407:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
3/27/202416:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
3/22/202416:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
3/15/202415:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
3/08/202415:05GLOBENurExone establishing State-of-the-Art Research and..
3/01/202415:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
2/20/202415:05GLOBENurExone’s Intellectual Property Portfolio Expands
2/14/202415:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
2/02/202415:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
1/17/202407:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
1/05/202407:30GLOBENurExone Announces Closing of a Private Placement for Gross..
11/29/202307:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
11/24/202307:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
10/30/202308:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
10/19/202307:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
10/11/202307:30GLOBENurExone Secures Eureka Grant for Collaborative..
10/05/202307:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
9/28/202307:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
9/13/202307:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
9/06/202307:30GLOBENurExone Announces Closing of Second Tranche of Private..

Your Recent History

Delayed Upgrade Clock